IKT β€” Inhibikase Therapeutics Inc

Ownership history in Siren, L.L.C.  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Inhibikase Therapeutics Inc (IKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.36% (2025 Q4)
πŸ“Š Avg. % of fund
0.36%
πŸ“… First filed
2025 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
1
% of Fund (quarterly)    IKT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 5,850,000 β€” β€” 0.36% $12.0M $2.05

🏒 Other funds also holding IKT

As of 2025 Q4 β€” sorted by position size

Sands Capital Alternatives, LLC 3Y 5.15% Stonepine Capital Management, LLC 3Y 7Y 3.51% Saturn V Capital Management LP 3Y 1.45% CAXTON CORP 3Y 7Y 1.36% Fairmount Funds Management LLC 3Y 1.35% ADAR1 Capital Management, LLC 1.2% Seven Fleet Capital Management LP 0.83% Soleus Capital Management, L.P. 3Y 0.82% Commodore Capital LP 3Y 0.74% Exome Asset Management LLC 0.59%
← Back to Siren, L.L.C. Holdings